Fast and easy monitoring
of CIPN

The Mediracer® NCS is intended to measure sensory nerve conduction from peripheral nerves for objective assessment of chemotherapy-induced peripheral neuropathy. Compact sized device is extremely user friendly for frequent monitoring during the chemotherapy treatment.

Easy monitoring of
Chemotherapy-Induced
Peripheral Neuropathy

cipn assessment tool

The diagnostic method is reliable and objective when detecting peripheral neuropathies. Examination will only take minutes for chemotherapy-induced peripheral neuropathy that afflicts large number of patients undergoing chemotherapy.

Mediracer® NCS is a certified class IIa medical device in Europe (CE), U.S. (FDA), Japan (PMDA), Korea (KFDA) and Australia (TGA).

Mediracer® NCS

Handheld Mediracer® NCS is reliable, fast and cost-efficient diagnostic tool for measuring sensory and motor nerve conduction. Mediracer® NCS requires only a short training to operate, and user-friendly analysis software makes the examination process straightforward. The handset is easy to use and the preconfigured disposable surface electrodes ensure easy and correct attachment.

Order Mediracer® NCS Brochure

Assessment solution for CIPN

Mediracer® NCS solution comprises of a handheld NCS device, disposal electrodes, sensory and/or motor cables, charger and analysis software for PC. Mediracer turnkey solution provides optional remote interpretation service by clinical neurophysiologist, or a platform for interpretation by a local doctor.

cipn device

Phone

+358 45 899 2626

Email

info@mediracer.com

Location

 Kasarmintie 13, 90130 Oulu Finland